# Congruence Therapeutics Announces Oral Presentation on CGX-195, a Novel Small Molecule AAT Corrector, at the ERS Alpha-1 Antitrypsin (AAT) Conference 2026

- Source: PR Newswire
- Published: 2026-10-23T15:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/congruence-therapeutics-announces-oral-presentation-on-cgx-195-a-novel-small-molecule-aat-corrector-at-the-ers-alpha-1-antitrypsin-aat-conference-2026-302918168.html
- Canonical: https://groundlevelnews.com/story/congruence-therapeutics-announces-oral-presentation-on-cgx-195-a-novel-51bcdf/

– CGX-195 increased functional, secreted Z-A1AT and reduced polymerized Z-A1AT in cellular assays and in the PiZ mouse model – MONTREAL, Oct. 23, 2026 /PRNewswire/ -- Congruence Therapeutics ("Congruence"), a clinical-stage, computationally driven biotechnology company building a pipeline...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire._